Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Givinostat in ambulant boys with Duchenne muscular dystrophy
2016-000401-36Phase 3Unknown
- Sponsor
- Italfarmaco
- Start
- Oct 2016
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Duchenne muscular dystrophy (DMD) comparing Givinostat with Placebo (2 arms). Primary endpoint: Mean change in 4SC. Status: unknown.
02
Drugs
givinostat
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on 2016-000401-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000401-36.